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IMPORTANCE No studies have systematically examined the accuracy of clinical, laboratory,
and imaging variables in detecting renal scarring in children and adolescents with a first
urinary tract infection.
OBJECTIVES To identify independent prognostic factors for the development of renal scarring
and to combine these factors in predictionmodels that could be useful in clinical practice.
DATA SOURCES MEDLINE and EMBASE.
STUDY SELECTION We included patients aged 0 to 18 years with a first urinary tract infection
who underwent follow-up renal scanning with technetium Tc 99m succimer at least 5 months
later.
DATA EXTRACTION AND SYNTHESIS Wepooled individual patient data from9 cohort studies.
MAIN OUTCOMES ANDMEASURES We examined the association between predictor variables
assessed at the time of the first urinary tract infection and the development of renal scarring.
Renal scarring was defined by the presence of photopenia on the renal scan. We assessed the
following 3models: clinical (demographic information, fever, and etiologic organism) and
ultrasonographic findings (model 1); model 1 plus serum levels of inflammatory markers
(model 2); andmodel 2 plus voiding cystourethrogram findings (model 3).
RESULTS Of the 1280 included participants, 199 (15.5%) had renal scarring. A temperature of
at least 39°C, an etiologic organism other than Escherichia coli, an abnormal ultrasonographic
finding, polymorphonuclear cell count of greater than 60%, C-reactive protein level of
greater than 40mg/L, and presence of vesicoureteral reflux were all associated with the
development of renal scars (P  .01 for all). Although the presence of grade IV or V
vesicoureteral reflux was the strongest predictor of renal scarring, this degree of reflux was
present in only 4.1% of patients. The overall predictive ability of model 1 with 3 variables
(temperature, ultrasonographic findings, and etiologic organism) was only 3% to 5% less than
the predictive ability of models requiring a blood draw and/or a voiding cystourethrogram.
Patients with a model 1 score of 2 or more (21.7% of the sample) represent a particularly
high-risk group in whom the risk for renal scarring was 30.7%. At this cutoff, model 1
identified 44.9% of patients with eventual renal scarring.
CONCLUSIONS AND RELEVANCE Children and adolescents with an abnormal renal
ultrasonographic finding or with a combination of high fever (39°C) and an etiologic
organism other than E coli are at high risk for the development of renal scarring.
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U rinary tract infection (UTI) is the most common seri-ous bacterial infection in young children. In approxi-mately 10% to 15% of cases, UTI leads to permanent
renal scarring.1 Substantial scarring leading to a reduction in
kidney function has been associated with hypertension, pre-
eclampsia, and end-stage renal disease decades later.2-6 The
exact incidence of end-stage renal disease attributable to re-
nal scarring secondary to UTIs during childhood remains un-
certain but appears to be rare.7
Our first objectivewas to identify independent prognostic
factors linked to the development of renal scarring and to de-
termine the importance of these factors relative to each other.
Conflictingdata,mostlyfromsmallstudies,exist regardingprog-
nostic factors for renal scarring.Forexample,age,delay in treat-
ment,male sex, and presence of fever have all been suggested
as important prognostic factors for renal scarring in some
studies8-10 but not in others.11-18 Furthermore, little data exist
regarding the relative importance of these factors. For ex-
ample, although the association between vesicoureteral re-
flux (VUR) and renal scarring has been a consistent finding in
the literature,1 themagnitude of the association between spe-
cific grades of VUR and renal scarring is less clear.
Our second objectivewas to develop an easily implement-
ableclinicalpredictionmodel thatcouldbeusedto identifychil-
dren at risk for renal scarring. Such identification is important
because children with scarring may benefit from closer fol-
low-up and/ormore aggressivemanagement. In childrenwith
a very low probability of scar formation, routine imaging may
result in more harm than benefit. Without a method of strati-
fying risk, all children with UTI are necessarily treated in the
samemanner.Uniformtreatmentmay lead toovertreatmentof
low-risk children and undertreatment of high-risk children.
Becauserenal scarring isuncommon,most individual stud-
ies are too small to allowmeaningfulmultivariatemodeling.19
Accordingly,weconductedameta-analysisusing individualpa-
tient data to address the questions posed in this study.
Methods
Design
Ourmeta-analysisused individual patientdata extracted from
cohort studies of children and adolescents (aged 0-18 years;
hereinafter referred to as children for purposes of this study)
with a first UTI who underwent renal scanning with techne-
tiumTc99m(99mTc)succimer (dimercaptosuccinicacid)at least
5months after the index episode. Approval by an ethics com-
mittee was not sought because this systematic review con-
sists of previously published studies.
SearchMethods for Identification of Studies
We searchedMEDLINE (1950 through September 27, 2011) and
EMBASE (1974 throughSeptember 27, 2011)usingMedical Sub-
jectHeadingsterms(technetium,Tc99mdimercaptosuccinicacid,
andurinary tract infection) and textwords (DMSA,dimercapto-
succinic, scintigra*,pyelonephritis, renal, kidney,pyelonephritis,
urinary tract infection*,vesicoureteral,nephropath*, scar*,dam-
age*,defect*,uptake,photopenia,andcontour*lesionphotopeni*).
The searchwas limited to studiesof childrenaged0 to 18years.
Twoauthors(N.S.andT.S.) independentlyscreenedthetitlesand
abstracts. This electronic searchwas supplemented by review
of the bibliographies of the articles included.
Inclusion Criteria
We included studies with positive findings of a urine culture,
defined by the recovery of any organisms from a suprapubic
specimen, more than 10 000 colony-forming units/mL from
a catheter-collected specimen, or more than 100 000 colony-
forming units/mL from a clean-voided or a bag specimen.
Studies that included only neonates (<2 months) were
excluded because the causes of scarring are likely different
in this population.
Exclusion Criteria
We excluded studies in which UTI was not themain criterion
for inclusion (ie, studies that included only a small, highly se-
lected subgroupof childrenwithUTI). Inclusionof such stud-
iesmayhavebiasedourresults.Forexample,weexcludedstud-
ies describing cohorts of children referred for 99mTc succimer
scanning because the reasons for referral could be related to
the predictors being evaluated. We also excluded studies de-
scribing a highly selected subgroup of patients such as post-
operative patientswith urologic abnormalities, childrenwith
VUR, and studies with more than 30% loss to or unavailabil-
ity for follow-up or with fewer than 25 participants. We lim-
ited the analysis to children and adolescents with a first-
diagnosed UTI in the hopes of minimizing the number of
patients with preexisting acquired lesions.
Methods of Contacting Authors of Included Studies
Weusedelectronicmailas themainmethodofcontactingstudy
authors. If the corresponding author didnot respond,we con-
tacted thecoauthors. If this attemptwasunsuccessful,weused
the telephone and regular mail to contact the authors.
Predictors
The following factorswere considered for inclusion in thepre-
dictionmodel: age, sex,measured temperature at the time of
diagnosis, durationof fever beforepresentation, gradeofVUR
(defined by the guidelines of the International Reflux Study
in Children),10 the organism isolated from culture (Escheri-
chia colivs other), results of renal ultrasonography (normal vs
any abnormality), and levels of inflammatory markers (C-
reactive protein, erythrocyte sedimentation rate, procalcito-
nin, and polymorphonuclear cells). In addition to data on the
primarypredictors, theyearofenrollmentandmethodofurine
collection (bag vs other) were also gathered. The use of anti-
microbial prophylaxis for VUR, recurrence of UTI, and evi-
dence of pyelonephritis on an early 99mTc succimer scanwere
not included in the models because these variables are not
known at the time of diagnosis of a first UTI.
Outcome
The presence or absence of renal scarring, defined as any pho-
topeniawithorwithout a change in the renal contour, onapla-
nar 99mTcsuccimerscanobtainedat least5monthsafter the ini-
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tialUTIwastheprimaryoutcomemeasure.Scarringismostcom-
monly manifested by the presence of wedge-shaped photon-
deficientareasonthescan. Insomestudies,anabnormal finding
on the renal scan was defined by the presence of photopenia,
whereas inothers itwasdefinedby thepresenceofphotopenia
plusa change incontour.Becausemost childrenwithphotope-
niaona late 99mTcsuccimer scanarealso likely tohavechanges
inrenalcontour,wefelt justifiedincombiningstudiesusingeither
definition. Insomeof the includedstudies, a late renal scanwas
not performed if results of an early scanwere shown to benor-
mal. Because children who have normal findings on an early
99mTc succimer scanwill invariably have normal findings on a
latescan,20 forthepurposeofthisstudy, thesechildrenwerepre-
sumed tohaveanormaloutcomeon the renal scan.Wechose5
months as the cutoff becausemore than 90%of abnormalities
notedonscans conductedat least 5monthsafter the indexUTI
arepersistent.21Becauseofthelowerspecificityofthe99mTcsuc-
cimer scan when using single-photon emission computed
tomography,22 studies using thismethodwere excluded.
Statistical Analysis
Ourgoalswere to identifyvariablespredictiveof renal scarring
inunivariateanalysisandcombinethemintomultivariatemod-
els. We developed and compared the predictive ability of 3 in-
creasinglyinvasivestrategiesforevaluatingafirst-diagnosedUTI
in children.We first examined howwell amodel that included
only information gathered routinely in clinical practice (his-
tory, examination results, and renal ultrasonographic find-
ings) could predict scarring (model 1). Next, we determined
whethertheadditionofseruminflammatorymarkerswould im-
prove thepredictiveabilityofmodel 1 (model 2).Finally,wede-
terminedwhether the addition of information about the pres-
ence and degree of VURwould improvemodel 2 (model 3).
We combined all individual participant data into a single
meta-analytic logisticregressionmodel (ie,a1-stageapproach).23
To account for heterogeneity between studies, all models in-
cluded a categorical variable termed study (with 9 categories, 1
foreachofthe9studies included).Predictorsassociatedwiththe
outcome(P < .25)24were includedinmultivariateanalysis.Back-
ward selection25wasused indeveloping the initialmodels.We
tested the impactofdroppingvariablesusing the likelihood ra-
tioteststatistic.Wealsocomparedtheβcoefficients inthenested
models; a change of 10%was considered significant.26 Finally,
we dichotomized continuous variables that remained in the
model based on clinically established cutoffs (temperature,
≥39°C27,28; C-reactive protein level, >40 mg/L29 [to convert to
nanomolesper liter,multiplyby9.524]).Foreachmodel,wede-
velopedariskscore30byassigningapoint score for thevariables
inthemodel.Weassignedascoreof1tothevariablewiththelow-
est regressioncoefficient.Thescore for the remainingvariables
wasobtainedbydividing their regressioncoefficientby theco-
efficientofthevariablewiththelowestregressioncoefficientand
then rounding to thenearest integer. The total score for agiven
model was calculated by adding the scores for each of the pre-
dictors included in thatmodel. For eachmodel,we then calcu-
latedthetestcharacteristics (sensitivity, specificity,positiveand
negativepredictivevalues, and likelihoodratios) forallpossible
scores.Theoverallpredictiveabilityof themodelwasestimated
by the area under the receiver operating characteristic curve.
Goodnessof fitwasassessedusing theHosmer-Lemeshowtest.
Internal validityof eachmodelwasassessedbyperforming the
bootstrap procedure (1000 iterations).
Subgroup Analysis
Weperformedsubgroupanalyseswith respect todysplasia, the
method of urine collection, and age. Congenital renal dyspla-
siamayaccount for someof theobserved lesions. Ifmany chil-
dren with dysplasia were included, then variables associated
withdysplasia insteadofacquiredscarringmighthavebeense-
lected for the models. However, all but 1 study explicitly ex-
cludedchildrenwithknowngenitourinaryanomalies.Further-
more,becausehigh-qualityprenatalultrasonographyhasbeen
routine inmost centers during the last 15 years,many patients
with significant congenital dysplasia would have been identi-
fied and thus excluded from these studies. In the subgroup
analysis,weexcludedchildrenwithpotentialdysplasia (ie, chil-
drenenrolledbefore1997orchildreninthe1studythatmayhave
included patients with preexisting genitourinary anomalies).
Becauseurine specimens collectedusingperineal bags are
oftencontaminated,weexamineddata in thesubgroupof chil-
dren inwhombagswerenot used. Finally, because thepatho-
physiological features ofUTI and/or scarringmaybedifferent
in neonates, we conducted an analysis excluding all children
younger than 2 months.
Results
Literature Search and Included Studies
Our search strategy yielded 1833 articles, of which 23 met our
inclusion criteria (eFigure in the Supplement).20,31-52 A list of
all excluded studies is available from the authors on request.
The authors of 9 of these articles provided data for anal-
ysis.20,33,35,38-40,42,48,49 The authors of the other 14 articles*
did not respond to requests for data or could not provide data
(eTable in the Supplement). Of the 14 excluded articles, 3 did
not provide data regarding the number of children with renal
scarring. The proportion of children with renal scarring in the
remaining 11 excluded articles was similar to that of the
included articles (P = .19). The characteristics of the 9 included
studiesaresummarized inTable1. Sixstudies33,35,38,42,48,49were
observational and 3 studies20,39,40were randomized trials. The
meannumberofchildren ineachstudywas171.Of the1479chil-
dren eligible for evaluation, 1280 had data on our primary out-
come, late 99mTc succimer scanning.
Participant Characteristics
Demographic, laboratory, and imaging characteristics of
these 1280 children are presented in Table 2; 64.6% were
girls; 82.7% were younger than 24 months; 48.1% had a tem-
perature of at least 39°C; and 8.4% were infected with an
organism other than E coli. The renal ultrasonographic find-
ing was abnormal in 19.9% of children. Any VUR and VUR of
grades IV to V was present in 29.1% and 4.1% of children,
*References 31, 32, 34, 36, 37, 41, 43-47, 50-52
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respectively. Renal scarring was present in 199 patients
(15.5%), and 100 of these (50.3%) had VUR. The proportion
of children with renal scarring increased with the increasing
grade of VUR (from 98 of 884 [11.1%] in children with no
VUR to 35 of 51 [68.6%] in children with grade IV or V VUR).
Risk Factors for Renal Scarring
The following factors were associated with renal scarring
(listed in descending order of importance): grade IV or V
VUR, abnormal ultrasonographic finding, grade III VUR,
C-reactive protein level of more than 40 mg/L, temperature
Table 1. Characteristics of the 9 Included Studies
Source
No. of
Children Location
Age Range,
mo Setting
Fever
Requirement
Prospective
Study
Bag
Collection
Excluded
Known Renal
Abnormalities
Bressan et al,33 2009 72 Europe 0.2-36 Outpatient Yes Yes Yes Yes
Craig et al,35 1998 304 Australia 0-60 Inpatient/outpatient No Yes Yes Yes
Hoberman et al,20 1999 309 United States 1-24 Inpatient/outpatient Yes Yes No Yes
Kotoula et al,38 2009 57 Europe 2-108 Inpatient No Yes Yes Not stated
Levtchenko et al,39 2001 80a Europe 1.5-180 Inpatient Yes Yes Yes Yes
Montini et al,40 2007 450b Europe 1-84 Inpatient No Yes Yes Yes
Prat et al,42 2003 77 Europe 1-144 Outpatient Yes Yes No Yes
Taskinen and Rönnholm,48
2005
62c Europe 0.2-186 Inpatient Yes Yes Yes Yes
Tuerlinckx et al,49 2005 68d Europe 1-168 Inpatient Yes Yes Yes Yes
a Includes only children with a first-diagnosed urinary tract infection (UTI);
9 children with missing late technetium Tc 99m succimer scans were excluded
in the original study but included here.
b Includes only eligible children with a UTI.
c Three children with genitourinary anomalies were excluded; 1 child with a low
C-reactive protein level was excluded in the original study but included here.
d Includes only children with a first-diagnosed UTI; 17 children with missing
procalcitonin levels were excluded in the original study but included here.
Table 2. Predictors of Renal Scarring in 1280 ChildrenWith a First-Diagnosed UTI
Characteristica
No. of
Patientsb
No (%) With
Scarring
OR for Scarring
(95% CI)c P Value
Age, mo
<24 1057 142 (13.4) 0.53 (0.36-0.78)
<.01
≥24 221 57 (25.8) 1 [Reference]
Sex
Female 827 135 (16.3) 1.33 (0.95-1.88)
.10
Male 452 64 (14.2) 1 [Reference]
Fever ≥39°C33,39,48
Yes 509 97 (19.1) 2.29 (1.57-3.34)
<.01
No 549 59 (10.7) 1 [Reference]
Fever duration >24 h35,38,39,42
Yes 376 57 (15.2) 1.11 (0.72-1.71)
.64
No 682 70 (10.3) 1 [Reference]
PMN count >60%33,42,48
Yes 363 83 (22.9) 1.91 (1.30-2.82)
<.01
No 494 58 (11.7) 1 [Reference]
CRP level >40 mg/L35
Yes 512 116 (22.7) 3.01 (1.97-4.57)
<.01
No 451 47 (10.4) 1 [Reference]
Organism other than Escherichia coli48
Yes 101 27 (26.7) 2.20 (1.34-3.62)
<.01
No 1105 159 (14.4) 1 [Reference]
Abnormal ultrasonographic finding39,48
Yes 224 71 (31.7) 3.79 (2.61-5.49)
<.01
No 902 100 (11.1) 1 [Reference]
VUR grade
None 884 98 (11.1) 1 [Reference] NA
I and II 200 35 (17.5) 1.82 (1.18-2.81) .01
III 112 30 (26.8) 3.56 (2.18-5.82) <.01
IV and V 51 35 (68.6) 22.48 (11.29-44.77) <.01
Abbreviations: CRP, C-reactive
protein; NA, not applicable; OR, odds
ratio; PMN, polymorphonuclear cell;
UTI, urinary tract infection;
VUR, vesicoureteral reflux.
SI conversion factor: To convert CRP
to nanomoles per liter, multiply by
9.524.
a Studies in which the given
characteristic was not evaluated are
cited by source.
bNumbers of children eligible for
evaluation vary for each
characteristic owing tomissing data
(number missing = 1280 − number
evaluable).
c Odds ratios are calculated from a
meta-analytic logistic regression
model that included a categorical
variable termed study.
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of at least 39°C, organism other than E coli, polymorpho-
nuclear cell count of more than 60%, and grade I or II VUR
(Table 2). The odds of renal scarring in children with grade IV
or V VUR were 22 times higher than in children with no VUR.
In contrast, the odds of renal scarring in children with grade I
or II VUR were only marginally higher than in children with
no VUR. Age, sex, and duration of fever before presentation
were not significantly associated with renal scarring. The
prevalence of renal scarring in boys younger than 6 months
(14.6%) was not significantly different from the prevalence in
the sample as a whole (P = .48). Because of the large amount
of missing data, procalcitonin levels and erythrocyte sedi-
mentation rate were not included in the models. In addition,
because some variables were not measured in some of the
studies, imputation was not possible.
Models for Renal Scarring
Table 3 summarizes the predictive abilities of the 3 multivar-
iatemodels.Model 1 includedabnormalultrasonographic find-
ings, an etiologic organism other than E coli, and fever of at
least 39°C as predictor variables. In addition to the 3 variables
in model 1, model 2 also included C-reactive protein level of
more than40mg/Landpolymorphonuclear cell countofmore
than 60%. Inmodel 3, the presence of grade IV or V VURwas
by far the variable most strongly associated with renal scar-
ring. Having an organism other than E coli or an abnormal ul-
trasonographic finding was no longer significant in model 3.
Theareasunder the receiver operating characteristic curve for
models 1, 2, and3were0.69,0.72, and0.74, respectively. Thus,
information about serumbiomarker levels andvoiding cysto-
urethrogram (VCUG)only increased thepredictive ability over
model 1 by 3 and 5 percentage points, respectively. The use of
dichotomous variables in the models (eg, using temperature
≥39°C instead of temperature as a continuous variable) was
accompanied by negligible (<1%) reductions in the predictive
ability of themodels.Owing tomissingdata in 1 ormoreof the
variables, models 1, 2, and 3 included 1053, 632, and 626 par-
ticipants, respectively.
The accuracy of eachmodel at predicting renal scarring at
selected cut points is presented in Table 4. Amodel 1 score of
2ormorehada sensitivity and specificity of 44.9%and82.4%,
respectively. Amodel 1 score of 2 ormore alsowould have de-
tected 68.2% of those patientswith grade IV or V VUR.Model
1wasvery robust; thevariables chosen for themodel and their
respectivepoint scoreswere identical in the subgroups exam-
ined. Subgroupanalysis for the 2othermodelswas limitedbe-
cause of small sample size, but in general these models ap-
peared to be less robust thanmodel 1. Specifically, for model
2, limiting by age or by year of enrollment affected themodel
little, but limiting bymethod of collection resulted in a parsi-
monious model (abnormal ultrasonographic results and not
E coli dropped out). For model 3, limiting by age or by year of
enrollment resulted in the sexvariable droppingout, and lim-
iting bymethod of collection resulted in changes in the point
scores (β coefficients) for someof the variables. For all 3mod-
els, themean area under the receiver operating characteristic
curve obtained via bootstrapping was very similar to the val-
ues reported above (difference of <1.5%).
Discussion
In this studyofan individualpatientdatameta-analysisof 1280
childrenwitha firstUTI from9studies,wedevelopedapredic-
tionmodel that provides clinicians with amethod of identify-
ing the subgroup of childrenwith a first UTIwho are at risk for
renal scarring.Ourdatashowthatchildrenwithamodel 1 (clini-
cal information and ultrasonographic finding) score of 0 or 1
(78.3% of the sample) are at low or intermediate risk for scar-
ring from their first-diagnosed UTI. These children have nor-
Table 3. Comparison of 3MultivariateModels in Predicting Renal Scarringa
Predictor Variable
Model 1b Model 2c Model 3d
OR (95% CI) P Value Pointse OR (95% CI) P Value Pointse OR (95% CI) P Value Pointse
Temperature ≥39°C 2.30 (1.56-3.40) <.001 1 1.81 (1.08-3.03) .03 1 1.78 (1.05-3.03) .03 1
Organism other than
Escherichia coli
2.31 (1.36-3.94) .002 1 2.33 (1.14-4.76) .02 1 NA NA NA
Abnormal ultrasonographic
finding
3.61 (2.42-5.37) <.001 2 2.13 (1.22-3.72) .01 1 NA NA NA
Female sex NA NA NA 1.89 (1.03-3.48) .04 1
PMN count >60% NA NA NA 2.17 (1.33-3.56) <.01 1 2.34 (1.40-3.93) <.01 1
CRP level >40 mg/L NA NA NA 2.66 (1.57-4.52) <.01 2 2.65 (1.53-4.59) <.01 2
VUR gradef
I and II NA NA NA NA NA NA NA NA NA
III NA NA NA NA NA NA 2.90 (1.48-5.71) <.01 2
IV and V NA NA NA NA NA NA 23.70 (6.56-85.63) <.01 6
Abbreviations: CRP, C-reactive protein; NA, not applicable; OR, odds ratio;
PMN, polymorphonuclear cell count; VUR, vesicoureteral reflux.
SI conversion factor: To convert CRP to nanomoles per liter, multiply by 9.524.
a Models are described in the Statistical Analysis subsection of theMethods
section.
b For model 1, the Hosmer-Lemeshow goodness of fit χ2 is 0.83; the area under
the receiver operating characteristic (ROC) curve is 0.69 (95% CI, 0.65-0.73).
c For model 2, the Hosmer-Lemeshow goodness of fit χ2 is 0.46; the area under
the ROC curve is 0.72 (95% CI, 0.67-0.77).
d For model 3, the Hosmer-Lemeshow goodness of fit χ2 is 0.17; the area under
the ROC curve is 0.74 (95% CI, 0.69-0.79).
e Ranges of points are 0 to 4, 0 to 6, and 0 to 13 for models 1, 2, and 3,
respectively.
f Categories are mutually exclusive for scoring purposes.
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mal renal ultrasonographic findings and nomore than 1 of the
following: temperatureofat least39°Coranorganismotherthan
E coli. Their risk for scarring (6.2% in childrenwith a score of 0
and 14.3% in children with a score of 1) is no higher than the
baseline risk (15.6%).Childrenwithamodel 1 scoreof 2ormore
(21.7%of the sample) represent a high-risk group inwhom the
risk for renal scarring is twice thebaseline risk (Table 5). These
children (1) have an abnormal renal ultrasonographic finding
or (2) have a temperature of at least 39°C and an etiologic or-
ganism other than E coli. Because approximately one-third of
childrenwith amodel 1 score of 2 ormore have renal scarring,
this groupmerits close clinical follow-upandconsideration for
a late 99mTcsuccimerscan.However, thepotentialmeritsofob-
taining a late scan clearly need to be explored in future pro-
spective studies before the scan can be recommended.
Wewere also able to determine the relative importance of
various independent predictors of renal scarring in patients
with first-diagnosedUTI. CurrentUTI guidelines recommend
performing renal ultrasonography for some children with a
first-diagnosed UTI but limit the recommendation to young
children53,54 or to childrenwith an atypical UTI.55,56 Our find-
ings suggest that renal ultrasonography is an important pre-
dictor of renal scarring regardless of age, sex, and clinical ap-
pearance. Furthermore, whereas the guidelines from the
National Institute forHealth andCareExcellence in theUnited
Kingdom55 identify infectionwithanorganismother thanEcoli
as an important risk factor, the guidelines from the American
Academyof Pediatrics in theUnited States54 donot. Our data,
which are consistent with those of previous studies,57,58 sug-
gest that infection with organisms other than E coli increases
the risk for renal scarring.
As expected, the presence of grade IV or VVURwas by far
the most important risk factor for the development of scar-
ring. This degree of VUR, however, was only present in 4.1%
of children. Thus, although our data confirm the importance
of high-grade VUR as a risk factor for renal scarring, they do
not resolve the difficult question of how to identify this im-
portant but small subgroup of childrenwithout subjecting all
children to a VCUG.
We also identified several factors that were not associated
withscarring. Incontrast tosomepreviousstudies,8-10,59,60most
ofwhichwerecompletedinthe1980s,youngerageandmalesex
werenot associatedwith an increased risk for renal scarring. In
fact,we found that older age and female sexwereweakpredic-
torsof renal scarring.Thisdiscrepancymaybe related tohigher
likelihoodof inclusionof childrenwithunrecognizeddysplasia
in someof these previous studies. Similar to recent reports,we
didnot findanassociationbetweenfeverdurationofmore than
24 hours before presentation and renal scarring.61,62 However,
this findingdoesnotmean that timelydiagnosis and treatment
ofUTIareunimportant.EarlydiagnosisofUTImaypreventpain
and discomfort, unnecessary diagnosticworkup for other con-
ditions, and progression from cystitis to pyelonephritis.61
Ourmeta-analysis has several limitations. First, not all eli-
gible studieswere included. However, we found no difference
betweenstudiesthatwereincludedandthosethatwereexcluded
withregard to theproportionwithrenal scarring.Second, 13.5%
ofchildrenhadnodataontheprimaryoutcome.Third,wewere
limited by the complete absence of some of our predictor vari-
ables fromsomeof the studies.This limitationwasparticularly
true for the serum inflammatorymarkers and VCUG tests. Be-
cause children who underwent blood collection or VCUGmay
havebeendifferentfromchildrenwhodidnotundergothesepro-
cedures,thecalculatedsensitivityandspecificityvaluesformod-
els 2 and 3maybe inaccurate. Fourth,wedidnot havedetailed
informationregardingtheimagingtests; forexample,moststud-
ies reported the ultrasonographic findings as normal or abnor-
mal. Fifth, themodelspresentedhereinneed tobevalidated in
Table 4. Comparison of the Accuracy of the 3Models in Predicting Renal Scarring
Model, Scorea Patients With Score, % Sensitivity, % Specificity, % PPV, %b NPV, %b Positive LR Negative LR
1
≥1 63.0 84.6 40.8 19.9 93.8 1.43 0.38
≥2 21.7 44.9 82.4 30.7 89.6 2.55 0.67
2
≥2 62.2 87.0 42.5 22.1 94.6 1.51 0.31
≥4 19.9 43.0 84.4 34.1 88.7 2.76 0.68
3
≥3 55.8 82.0 49.2 23.5 93.5 1.62 0.37
≥5 18.1 49.0 87.8 43.4 90.1 4.03 0.58
Abbreviations: LR, likelihood ratio; NPV, negative predictive value; PPV, positive predictive value.
a Models are described in the Statistical Analysis subsection of theMethods section.
bCalculated using observed prevalence for renal scarring (15.6%).
Table 5. Risk for Renal Scarring byModel 1 Scorea
Score No. of Patients
Patients With Scarring,
No. (%)
Patients With VUR Grade IV or V,
No./Total No. (%) Risk
0 390 24 (6.2) 5/384 (1.3) Very low
1 435 62 (14.3) 9/423 (2.1) Intermediate
≥2 228 70 (30.7) 30/228 (13.2) High
Total 1053a 156 (14.8) 44/1035 (4.3) Baseline
Abbreviation: VUR, vesicoureteral
reflux.
a Includes only the 1053 children in
model 1.
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an independentdata set.Finally, althoughour sample likely in-
cludedsomechildrenwithcongenitalrenaldysplasia,thisreflects
the spectrum of renal parenchymal abnormalities observed in
practice. Furthermore, because identification of childrenwith
dysplasiacouldbepotentiallyhelpful,detectionofsuchchildren
using theprediction rulespresentedcouldbeconsideredanad-
vantage rather than a limitation.
We chose scarring and not VUR as our primary outcome
variable because scarring is more likely to affect renal func-
tion. In addition, selecting scarring as theprimaryoutcomeal-
lowed us to show the degree to which various grades of VUR
affect long-term renal scarring.
Conclusions
To our knowledge, this study is the first to combine individual
patientdata frommultiplestudies (9studies including1280chil-
dren) to identifyvariablespredictiveof renal scarring.Because
we includedstudies thatwere conductedat a timewhenVCUG
was routinely recommended, wewere able to assess the addi-
tional predictive ability of 3 increasingly invasive models. We
foundthatusingasimplemodelwithonly3clinicalvariablespro-
videdareasonablescreeningstrategy.The21.7%ofchildreniden-
tifiedashigh risk through this strategywould include44.9%of
all childrenwho scar. Early identification of children at risk for
renal scarringusing thepredictionrulesdeveloped in this study
couldhelpcliniciansdeliverspecific treatmentandfollow-upfor
thissmallsubgroupinthefuture.Onesmallstudysuggestedthat
treatmentwithcorticosteroids inchildrenwith febrileUTImay
decreaserenalscarring.63Thisconclusion isbeingfurtherevalu-
atedinalargertrial.64 Inaddition,moreaggressivefollow-up(eg,
antibioticprophylaxis, imaging, and timely treatmentof recur-
rentUTI)mayprevent further renaldamage.Although littleevi-
denceexists that supports theefficacyof thesemeasuresat this
time, several ongoing studiespromise toprovideusefuldata in
thenear future.65Wearehopeful thatdata fromthisstudy,along
withemergingdatafromlongitudinalandbiomarkerstudies,can
be used to develop individualized care plans for childrenwith
a first UTI.
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